SWEETY MATHEW, Regulatory Professional, RA CMC Biotech & Rare Disease, Novo Nordisk

•   Sweety Mathew is part of Global Regulatory Affairs- CMC Rare Diseases team in Novo Nordisk and was earlier associated with Biocon Biologics handling peptides and biosimilars.

•   Prior to being a Regulatory professional, she was associated with BioMarin Pharma- UK (Rare Diseases) and part of RnD team as a Cell and Molecular Biologist.

•   She is a post graduate in Bioinformatics and Applied Biotechnology from University of Westminster, London.

•   She believes in nurturing an inquisitive and an explorative culture to be part of this exciting race to create a more scientifically advanced tomorrow.